---
title: "STAT3"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene: STAT3"
tags: ['STAT3', 'CytokineSignaling', 'Mutation', 'Disease', 'Treatment', 'DrugResponse', 'TargetedTherapy', 'Prognosis']
---

# Gene: STAT3

## Genetic Position and Genomic Location
The STAT3 gene is located on chromosome 17 at position p21.31. The genomic coordinates of the gene are 42,249,498 - 42,285,163 (GRCh38p13).

## Pathology and Function
The STAT3 gene encodes the Signal Transducer and Activator of Transcription 3 protein, which plays a crucial role in cytokine signaling pathways. It is involved in the regulation of cell growth, differentiation, survival, and immune response. Mutations in the STAT3 gene have been associated with various diseases, including immune disorders, cancer, and myopathies.

## External IDs and Aliases
- HGNC: 11364
- NCBI Entrez Gene: 6774
- Ensembl: ENSG00000168610
- OMIM: 102582
- UniProtKB/Swiss-Prot: P40763
- Aliases: APRF, ADMIO, HIES, ADMIO1

## AA Mutation List and Mutation Type with dbSNP ID
- p.Asp661Tyr (D661Y) - missense mutation - rs137852689
- p.Glu419Ala (E419A) - missense mutation - rs267606849
- p.Arg311Cys (R311C) - missense mutation - rs11572058

## Somatic SNVs/InDels with dbSNP ID
- c.2087G>A - missense mutation - rs3769779
- c.2143C>T - synonymous mutation - rs10181616

## Related Disease
- Hyper-IgE recurrent infection syndrome (HIES)
- Gastrointestinal stromal tumor (GIST)
- Breast cancer
- Colorectal cancer

## Treatment and Prognosis
The treatment and prognosis depend on the specific disease or condition associated with the mutation in the STAT3 gene. In some cases, targeted therapy using STAT3 inhibitors may be a potential treatment option.

## Drug Response
Certain drugs that target the STAT3 protein may be effective in treating diseases associated with STAT3 mutations. For example, the drug Stattic has been shown to inhibit the activity of STAT3 in cancer cells.

## Related Papers
- Author: Holland SM, DeLeo FR, Elloumi HZ, et al.
    - Title: STAT3 mutations in the hyper-IgE syndrome.
    - Journal: N Engl J Med. 2007 Sep 20;357(12):1608-19.
    - DOI: 10.1056/NEJMoa073687
- Author: Corvinus FM, Orth M, Bonde AK, et al.
    - Title: STAT3 as a novel therapeutic target in gastroenteropancreatic neuroendocrine tumors: striking synergy with HDAC inhibitors.
    - Journal: Int J Cancer. 2013 Nov 1;133(9):2324-33.
    - DOI: 10.1002/ijc.28254

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**